Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

233
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
233
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

119
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
119
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Psychiatric Outcomes after GLP-1 Receptor Agonists versus Metformin in Hidradenitis Suppurativa.

Skin appendage disorders·2026
Same author

Comparison of Specific Glucagon-Like Peptide-1 Receptor Agonists on Kidney Outcomes Among Patients With Type 2 Diabetes.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Study of Metformin and GLP-1 Receptor Agonist Use in Hidradenitis Suppurativa Using the NIH All of Us Research Program.

Diabetes care·2026
Same author

Further Methodological and Clinical Reflections-Reply.

JAMA otolaryngology-- head & neck surgery·2026
Same author

Encounter tool for Shared Decision Making about Adjuvant Treatment of Lung Cancer: Randomized Clinical Trial.

Research square·2026
Same author

Comparative effectiveness of sulfonylureas on kidney outcomes in adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulation.

BMJ open diabetes research & care·2026

相关实验视频

Updated: Jun 3, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.0K

多学科的利益相关者参与了2型糖尿病的比较有效性研究,利用现实世界的数据.

Elizabeth H Golembiewski1,2, Mindy M Mickelson3, Juan P Brito1,4

  • 1Knowledge and Evaluation Research (KER) Unit, Mayo Clinic, Rochester, MN, USA.

Journal of clinical and translational science
|January 10, 2025
PubMed
概括

让患者和利益相关者参与使用真实世界数据进行比较有效性研究 (CER) 是至关重要的. 一个患者和利益相关者咨询小组 (PSAG) 改善了研究设计和对2型糖尿病 (T2D) 研究的相关性.

关键词:
患者和利益相关者参与参与.比较有效性研究比较有效性研究患者为中心的结果.现实世界的数据.2 型糖尿病 2 型糖尿病

更多相关视频

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

1.6K
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

196

相关实验视频

Last Updated: Jun 3, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.0K
Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

1.6K
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

196

科学领域:

  • 医疗保健服务研究 医疗服务研究
  • 相对有效性研究研究比较
  • 现实世界的数据研究研究.

背景情况:

  • 患者和利益相关者的参与对于比较有效性研究 (CER) 至关重要.
  • 使用真实世界数据 (RWD) 参与CER的各种利益相关者的例子是有限的.
  • 使用RWD的CER研究对利益相关者参与提出了独特的挑战,原因是技术复杂性和最小的前性数据收集.

研究的目的:

  • 描述患者和利益相关者参与2型糖尿病 (T2D) CER研究,使用RWD.
  • 评估患者和利益相关者咨询小组 (PSAG) 对研究设计和进行的影响.
  • 评估PSAG成员的满意度和感知目标.

主要方法:

  • 成立一个由12名成员组成的PSAG,包括T2D患者,临床医生,卫生系统领导人,专业社会代表和付款人代表.
  • PSAG指导了使用行政索赔数据进行T2D CER研究的研究设计,进行和传播.
  • 对PSAG成员进行研究后调查,以评估参与目标和经验.

主要成果:

  • PSAG成员影响了研究的关键决策,包括队列选择和添加患者偏好诱导目标.
  • PSAG成员报告的高满意度与参与过程有关.
  • PSAG成员的主要目标包括影响T2D患者的生活,并确保临床相关性.

结论:

  • 在基于RWD的CER中,利益相关方参与的最佳实践仍在发展.
  • 一种包容性,与利益相关者参与的方法通过整合多样化的观点来增强CER.
  • 未来的工作将重点关注长期参与成果和持续的PSAG成员满意度.